Capricor Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CAPR on Nasdaq
Location
8840 Wilshire Blvd, 2 Nd Floor, Beverly Hills, CA

Insiders trading volume in the past year

Capricor Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nippon Shinyaku Co Ltd 10%+ Owner $38M +$15M +65.2% Sep 20, 2024
Linda Marban CHIEF EXECUTIVE OFFICER, Director $276K Jan 2, 2024
Frank Litvack Director $185K Jan 2, 2024
David B. Musket Director $123K +$15.5K +14.3% Aug 7, 2024
Louis Manzo Director $86.4K Feb 21, 2023
Earl M. Collier Jr Director $79K +$28.3K +55.8% Apr 23, 2024
George W. Dunbar Jr Director $14.7K Jan 2, 2024
Paul Gisbert Auwaerter Director $6.95K +$14.2K Jan 2, 2024
Anthony Bergmann Chief Financial Officer $3.31K Jan 2, 2024
Mike Kelliher Director Jan 2, 2024
Xavier Avat Former CBO Apr 17, 2023
Karen Krasney Evp, General Counsel Jan 2, 2024
Philip J. Gotwals Director Jan 2, 2024
Karimah Es Sabar Director Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Capricor Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.